These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Some effects of oral contraceptives on carbohydrate metabolism. Wynn V; Doar JW Lancet; 1969 Oct; 2(7624):761-5. PubMed ID: 4186019 [No Abstract] [Full Text] [Related]
3. The haemostatic mechanism in oral contraception. Hilden M; Amris CJ; Starup J Acta Obstet Gynecol Scand; 1967; 46(4):562-71. PubMed ID: 6082549 [No Abstract] [Full Text] [Related]
4. [Metabolic and vascular consequences of hormonal contraception in non-diabetics]. Basdevant A; Guy-Grand B Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613 [No Abstract] [Full Text] [Related]
5. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature. Dugdale M; Masi AT J Chronic Dis; 1971 Mar; 23(10):775-90. PubMed ID: 4933752 [No Abstract] [Full Text] [Related]
6. [The metabolic effects of contraception with oestrogen-progestogen products (author's transl)]. Heim J J Gynecol Obstet Biol Reprod (Paris); 1979; 8(8):745-9. PubMed ID: 233376 [TBL] [Abstract][Full Text] [Related]
7. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
8. [Oral contraceptives and vitamins]. Larsson-Cohn U Lakartidningen; 1974 Mar; 71(10):956-60. PubMed ID: 4596797 [No Abstract] [Full Text] [Related]
10. Oestrogens and blood coagulation. von Kaulla KN Triangle; 1976; 15(1):9-17. PubMed ID: 785733 [No Abstract] [Full Text] [Related]
11. [The influence of estrogen-gestagen combination preparations on carbohydrate and fat metabolism. II. The effect of Antigest]. Göretzlehner G Zentralbl Gynakol; 1973 Sep; 95(36):1265-71. PubMed ID: 4767218 [No Abstract] [Full Text] [Related]
13. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy. Horwitt MK; Harvey CC; Dahm CH Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436 [TBL] [Abstract][Full Text] [Related]
14. [Influence of ovulation inhibitors on glucose metabolism]. Hausmann L; Kaffarnik H Dtsch Med Wochenschr; 1975 Aug; 100(34):1703-9. PubMed ID: 1098884 [TBL] [Abstract][Full Text] [Related]
15. [Metabolic studies under administration of oral contraceptives. A review]. Hauschildt S Z Ernahrungswiss; 1978 Mar; 17(1):1-18. PubMed ID: 349901 [TBL] [Abstract][Full Text] [Related]
16. [Physiology and clinical aspects of contraceptives of the hormonal type]. Benagiano G; Kincl FA; Rudel HH Minerva Med; 1968 Mar; 59(18):963-76. PubMed ID: 5646212 [No Abstract] [Full Text] [Related]
17. Tryptophan and oral contraceptives. Toseland PA; Price S Br Med J; 1969 Mar; 1(5646):777. PubMed ID: 5769868 [No Abstract] [Full Text] [Related]
18. The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure. Spellacy WN; Birk SA Am J Obstet Gynecol; 1972 Apr; 112(7):912-9. PubMed ID: 4114467 [No Abstract] [Full Text] [Related]